Peter S. Creticos, MD
Associate Professor of Medicine
Johns Hopkins University School of Medicine
Clinical Director, Division of Allergy and Clinical Immunology
Medical Director, Asthma and Allergy Diseases
Johns Hopkins Asthma and Allergy Center
• Dr Creticos reports receiving grant/research support from, serving as a consultant to, and is a member of the speakers' bureau for Allergenics, Aradigm, Aventis, AstraZeneca, Dynavax, GlaxoSmithKline, Merck, Muro, Pfizer, Pilot Therapeutics, Schering-Plough, and Stallergenes.
Michael S. Blaiss, MD
Clinical Professor of Pediatrics and Medicine
University of Tennessee Center of Health Sciences
College of Medicine
• Dr Blaiss reports receiving honoraria from, serving as a consultant to, and is a shareholder for GlaxoSmithKline, Merck, and Aventis.
Richard D. O'Connor, MD
Clinical Professor of Pediatrics
University of California, San Diego
Director of Quality Management
Sharp Rees-Stealy Medical Centers
Division of Asthma, Allergy, and Clinical Immunology
San Diego, California
• Dr O'Connor reports serving as a consultant to Health Benchmarks Inc. and on the speakers' bureau for GlaxoSmithKline, Aventis, Pfizer, Shering, and Pharmacia, and is a shareholder for Elan, GlaxoSmithKline, and Forest.
Samy Suissa, PhD
Director, Division of Clinical Epidemiology
McGill University Health Center
Royal Victoria Hospital
• Dr Suissa reports receiving grant/research support from AstraZeneca, GlaxoSmithKline, Boehringer Ingelheim, and Schering-Plough; and serving as a consultant to Organon.
Advanced Studies in Medicine provides disclosure information from contributing authors, participating faculty, and presenters only. Advanced Studies in Medicine does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.